6ER-008 Development of a risk-sharing model based on the clinical performance of onasemnogene abeparvovec (Zolgensma)

Autor: AC Martins De Figueiredo, RP Pinheiro Gonçalves Marques, AP Mecheiro De Almeida Martins Silvestre Correia, AF Cosme Silva
Rok vydání: 2022
Zdroj: Section 6: Education and research.
DOI: 10.1136/ejhpharm-2022-eahp.358
Databáze: OpenAIRE